Literature DB >> 26582428

Retinal involvement in amyotrophic lateral sclerosis: a study with optical coherence tomography and diffusion tensor imaging.

Annemarie Hübers1, Hans Peter Müller1, Jens Dreyhaupt2, Kathrin Böhm1, Florian Lauda1, Hayrettin Tumani1, Jan Kassubek1, Albert C Ludolph1, Elmar H Pinkhardt3.   

Abstract

Although motor neuron degeneration is the predominant feature in ALS, recent data point to a more widespread pathology also comprising non-motor symptoms. Retinal thinning has been reported in a variety of neurodegenerative conditions. Yet, studies of retinal involvement in ALS are sparse and results are heterogeneous. We studied retinal alterations in ALS using a systematic approach combining Optical Coherence Tomography (OCT), Diffusion Tensor Imaging (DTI) and clinical phenotyping. We hypothesized that selective changes of specific retinal layers may be a reflection of overall neurodegeneration as measured by DTI. Spectral domain OCT images were analyzed to calculate the average thickness of retinal layers in 71 ALS patients and 20 controls. In 30 patients, the region of interest (ROI) based fractional anisotrophy (FA) was measured in the corticospinal tract (CST), as this region is preferentially affected by motor neuron degeneration. Clinical data were collected for correlation analysis. Patients showed a significant thinning of the inner nuclear layer (INL; p = 0.04) and the retinal nerve fibre layer (RNFL; p = 0.004) compared to controls. We saw significant correlations between retinal thickness and FA values of the CST in patients (p = 0.005). No significant correlation between clinical parameters and retinal involvement was observed. Our study provides evidence for a retinal involvement in ALS. Interestingly, ALS patients show a reduction in FA of the CST, which is correlated to retinal thinning. We conclude that retinal involvement is in fact associated to overall neurodegeneration and may be regarded as a potential technical biomarker in ALS.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Neurodegeneration; Optical coherence tomography; Retina; Technical biomarker

Mesh:

Year:  2015        PMID: 26582428     DOI: 10.1007/s00702-015-1483-4

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  39 in total

Review 1.  Neurophysiological evaluation of cortical function in the early diagnosis of ALS.

Authors:  A Eisen; M Weber
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-03

Review 2.  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Authors:  B R Brooks; R G Miller; M Swash; T L Munsat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

Review 3.  The problem of functional localization in the human brain.

Authors:  Matthew Brett; Ingrid S Johnsrude; Adrian M Owen
Journal:  Nat Rev Neurosci       Date:  2002-03       Impact factor: 34.870

4.  Advances in the application of MRI to amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Michel Modo
Journal:  Expert Opin Med Diagn       Date:  2010-11

5.  The Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen: a cross-sectional comparison of established screening tools in a German-Swiss population.

Authors:  Dorothée Lulé; Christian Burkhardt; Susanne Abdulla; Sarah Böhm; Katja Kollewe; Ingo Uttner; Sharon Abrahams; Thomas H Bak; Susanne Petri; Markus Weber; Albert C Ludolph
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-10-08       Impact factor: 4.092

6.  Assessment of white matter tract damage in patients with amyotrophic lateral sclerosis: a diffusion tensor MR imaging tractography study.

Authors:  F Agosta; E Pagani; M Petrolini; D Caputo; M Perini; A Prelle; F Salvi; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-15       Impact factor: 3.825

7.  Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease.

Authors:  Anat Kesler; Veronika Vakhapova; Amos D Korczyn; Elvira Naftaliev; Meira Neudorfer
Journal:  Clin Neurol Neurosurg       Date:  2011-03-31       Impact factor: 1.876

8.  Decreased motor cortex γ-aminobutyric acid in amyotrophic lateral sclerosis.

Authors:  B R Foerster; B C Callaghan; M Petrou; R A E Edden; T L Chenevert; E L Feldman
Journal:  Neurology       Date:  2012-04-18       Impact factor: 9.910

9.  Diffusion tensor magnetic resonance imaging in the analysis of neurodegenerative diseases.

Authors:  Hans-Peter Müller; Jan Kassubek
Journal:  J Vis Exp       Date:  2013-07-28       Impact factor: 1.355

10.  Subtle retinal pathology in amyotrophic lateral sclerosis.

Authors:  Marius Ringelstein; Philipp Albrecht; Martin Südmeyer; Jens Harmel; Ann-Kristin Müller; Nazmiye Keser; David Finis; Stefano Ferrea; Rainer Guthoff; Alfons Schnitzler; Hans-Peter Hartung; Axel Methner; Orhan Aktas
Journal:  Ann Clin Transl Neurol       Date:  2014-03-11       Impact factor: 4.511

View more
  16 in total

Review 1.  Retinal microvascular network alterations: potential biomarkers of cerebrovascular and neural diseases.

Authors:  Delia Cabrera DeBuc; Gabor Mark Somfai; Akos Koller
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-12-06       Impact factor: 4.733

2.  Microglial activation in an amyotrophic lateral sclerosis-like model caused by Ranbp2 loss and nucleocytoplasmic transport impairment in retinal ganglion neurons.

Authors:  Kyoung-In Cho; Dosuk Yoon; Minzhong Yu; Neal S Peachey; Paulo A Ferreira
Journal:  Cell Mol Life Sci       Date:  2019-04-03       Impact factor: 9.261

3.  Reduced retinal nerve fiber layer (RNFL) thickness in ALS patients: a window to disease progression.

Authors:  Mohammad Rohani; Alipasha Meysamie; Babak Zamani; Mohammad Mahdi Sowlat; Fahimeh Haji Akhoundi
Journal:  J Neurol       Date:  2018-04-30       Impact factor: 4.849

4.  In vivo assessment of retinal vessel pathology in amyotrophic lateral sclerosis.

Authors:  A Abdelhak; A Hübers; K Böhm; A C Ludolph; J Kassubek; E H Pinkhardt
Journal:  J Neurol       Date:  2018-02-20       Impact factor: 4.849

Review 5.  Optical Coherence Tomography Angiography in Neurodegenerative Diseases: A Review.

Authors:  Georgios Tsokolas; Konstantinos T Tsaousis; Vasilios F Diakonis; Artemis Matsou; Straton Tyradellis
Journal:  Eye Brain       Date:  2020-07-14

6.  High and Low Contrast Visual Acuity Are Not Affected in Amyotrophic Lateral Sclerosis.

Authors:  Heather E Moss; Monica Samelson; Girish Mohan; Qin Li Jiang
Journal:  PLoS One       Date:  2016-12-29       Impact factor: 3.240

7.  Retinal thinning in amyotrophic lateral sclerosis patients without ophthalmic disease.

Authors:  Nisha Mukherjee; Shan McBurney-Lin; Anthony Kuo; Richard Bedlack; Henry Tseng
Journal:  PLoS One       Date:  2017-09-25       Impact factor: 3.240

Review 8.  Artificial intelligence extension of the OSCAR-IB criteria.

Authors:  Axel Petzold; Philipp Albrecht; Laura Balcer; Erik Bekkers; Alexander U Brandt; Peter A Calabresi; Orla Galvin Deborah; Jennifer S Graves; Ari Green; Pearse A Keane; Jenny A Nij Bijvank; Josemir W Sander; Friedemann Paul; Shiv Saidha; Pablo Villoslada; Siegfried K Wagner; E Ann Yeh
Journal:  Ann Clin Transl Neurol       Date:  2021-05-19       Impact factor: 4.511

9.  Discrepancy between NTG and POAG with corneal nerves in CCM.

Authors:  Dl Jing; Zy Liu; Yl Chou; Hk Wang; S Gao; X Fan; W Wang
Journal:  Eye (Lond)       Date:  2021-08-02       Impact factor: 4.456

10.  Macular sub-layer thinning and association with pulmonary function tests in Amyotrophic Lateral Sclerosis.

Authors:  Joseph M Simonett; Russell Huang; Nailah Siddique; Sina Farsiu; Teepu Siddique; Nicholas J Volpe; Amani A Fawzi
Journal:  Sci Rep       Date:  2016-07-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.